prrsv
pedv
antivir
inhibitor
broadspectrum
proteas
b
r
c
porcin
reproduct
respiratori
syndrom
viru
prrsv
porcin
epidem
diarrhea
viru
pedv
highli
virul
contagi
porcin
pathogen
caus
tremend
econom
loss
swine
industri
worldwid
current
effect
treatment
prrsv
pedv
commerci
vaccin
induc
steril
immun
studi
screen
librari
compound
identifi
two
specif
inhibitor
design
compound
target
prrsv
serin
proteas
first
evalu
inhibitori
effect
compound
prrsv
activ
next
determin
antiprrsv
capac
compound
cell
obtain
ec
cc
valu
cc
cc
respect
importantli
compound
also
target
pedv
proteas
proteas
inhibit
pedv
replic
show
ec
cc
valu
cc
cc
respect
final
result
indic
activ
site
proteas
conserv
contact
compound
via
hydrogen
bond
hydrophob
forc
put
substratebind
model
summari
compound
exhibit
broadspectrum
antivir
activ
may
facilit
develop
antivir
drug
prrsv
pedv
nidovirus
import
pathogen
human
livestock
envelop
plusstrand
rna
virus
compris
famili
arterivirida
coronavirida
gorbalenya
et
al
porcin
reproduct
respiratori
syndrom
viru
prrsv
member
famili
arterivirida
snijder
et
al
major
threat
worldwid
swine
industri
sinc
discoveri
earli
wensvoort
et
al
collin
et
al
highli
pathogen
porcin
reproduct
respiratori
syndrom
viru
hpprrsv
emerg
prevail
mainland
china
result
devast
damag
swine
product
tian
et
al
current
hpprrsv
caus
high
morbid
high
mortal
infect
pig
age
remain
major
threat
swine
produc
china
surround
countri
han
et
al
porcin
epidem
diarrhea
viru
pedv
member
genu
alphacoronaviru
song
park
first
identifi
china
xuan
et
al
pedv
caus
contagi
intestin
diseas
call
porcin
epidem
diarrhea
ped
character
vomit
diarrhea
dehydr
octob
largescal
outbreak
ped
caus
pedv
variant
occur
china
result
tremend
econom
loss
li
et
al
wang
et
al
wang
et
al
tian
et
al
prrsv
pedv
highli
virul
contagi
porcin
pathogen
caus
respiratori
enter
diseas
pig
result
signific
econom
loss
intens
pig
product
worldwid
li
et
al
snijder
et
al
wang
et
al
prrsv
pedv
genom
compris
approxim
genom
encod
polyprotein
cleav
viral
proteas
intermedi
matur
nonstructur
protein
ziebuhr
et
al
gorbalenya
et
al
viral
proteas
involv
polyprotein
cleavag
papainlik
proteas
serin
proteas
prrsv
pedv
proteas
tian
et
al
ye
et
al
replic
proteas
cleav
nproxim
region
proteas
cleav
viral
polyprotein
conserv
interdomain
junction
tian
et
al
ye
et
al
viral
proteas
play
essenti
role
artertiviru
coronaviru
replic
therefor
receiv
much
attent
potenti
key
antivir
target
includ
tgev
fipv
ibv
sarscov
anand
et
al
kim
et
al
lee
et
al
xue
et
al
rna
virus
prrsv
pedv
prone
mutat
select
pressur
field
may
caus
frequent
appear
new
variant
strain
han
et
al
moreov
current
commerci
vaccin
approach
prrsv
pedv
partial
effect
du
et
al
b
date
effect
broadspectrum
antivir
drug
prrsv
pedv
infect
avail
although
antivir
compound
report
previous
karuppannan
et
al
st
john
et
al
evan
et
al
remain
impedi
identifi
new
inhibitor
target
prrsv
pedv
proteas
use
antivir
therapi
diseas
epidem
studi
find
provid
new
insight
molecular
mechan
underli
proteasemedi
inhibit
viral
replic
may
also
guid
develop
new
broadspectrum
antivir
drug
lowmolecularweight
fragmentbas
librari
contain
approxim
compound
spec
delf
netherland
use
antivir
fragment
screen
fragment
defin
small
molecul
obey
congrev
rule
three
molecular
weight
mw
number
hydrogen
donor
acceptor
clogp
congrev
et
al
compound
dissolv
dimethyl
sulfoxid
dmso
mpbio
concentr
mm
moreov
compound
prepar
dmso
stock
solut
mm
cell
prrsvpermiss
cell
line
deriv
cell
kim
et
al
african
green
monkey
cell
vero
cell
cultur
dulbecco
minimum
essenti
medium
dmem
hyclon
supplement
fetal
bovin
serum
gibco
co
moreov
hpprrsv
strain
genbank
access
li
et
al
pedv
fjzz
strain
genbank
use
assay
express
prrsv
code
sequenc
pcramplifi
prrsv
strain
cdna
librari
insert
ctermin
tag
ndei
bamhi
restrict
site
construct
valid
dna
sequenc
plasmid
transform
escherichia
coli
strain
cell
cultur
lb
medium
contain
mgl
kanamycin
optic
densiti
od
reach
cultur
cool
supplement
mm
iptg
isopropyldthiogalactopyranosid
overnight
induct
cell
harvest
via
centrifug
rpm
min
protein
purif
follow
previous
report
procedur
shi
et
al
final
harvest
protein
concentr
volum
approxim
ml
filter
use
superdex
gel
filtrat
column
ge
healthcar
equilibr
buffer
mm
trishcl
mm
nacl
ph
concentr
purifi
protein
determin
detect
absorb
use
nanodrop
uvvi
spectrophotomet
thermo
fisher
scientif
pedv
proteas
express
purif
carri
follow
previous
report
procedur
polypeptid
substrat
tian
et
al
chemic
synthes
genscript
corpor
prrsv
pedv
proteas
use
final
concentr
respect
compound
variou
concentr
preincub
proteas
min
substrat
proteas
substrat
ad
mixtur
black
plate
mixtur
incub
min
enhanc
fluoresc
due
substrat
cleavag
proteas
monitor
excit
emiss
rel
fluoresc
unit
rfu
calcul
subtract
background
substrat
control
well
without
proteas
fluoresc
read
percentag
inhibit
calcul
follow
percentag
inhibit
rfu
experiment
group
min
rfu
control
group
min
cell
death
toxic
concentr
cc
compound
cell
vero
cell
determin
follow
previous
report
procedur
shi
et
al
briefli
confluent
cell
grown
white
plate
corn
tewksburi
usa
treat
variou
concentr
compound
h
cell
vero
cell
treat
dmso
control
cell
cytotox
measur
use
celltiterglo
luminesc
cell
viabil
assay
reagent
promega
madison
wi
usa
cell
seed
plate
densiti
cell
per
well
cell
grown
confluenc
prrsv
ad
increas
concentr
compound
multipl
infect
moi
supernat
contain
viru
compound
use
infect
cell
h
harvest
supernat
includ
prrsv
compound
use
tcid
assay
briefli
cell
seed
plate
infect
serial
dilut
supernat
use
eight
replic
tcid
assay
plate
incub
h
viral
titer
calcul
tcid
assay
pedv
also
perform
follow
method
cell
vero
cell
seed
plate
densiti
cell
per
well
cell
grown
confluenc
prrsv
strain
pedv
fjzz
strain
inocul
cell
moi
virusinfect
cell
incub
presenc
compound
h
compoundtr
prrsvpedvinfect
control
cell
dmso
lyse
lysi
buffer
mm
tri
ph
mm
nacl
triton
contain
proteinas
inhibitor
beyotim
supernat
harvest
total
protein
sampl
measur
use
bca
protein
assay
kit
thermo
scientif
equal
amount
protein
sampl
analyz
perform
sdspage
follow
transfer
pvdf
membran
biorad
block
membran
incub
overnight
antiprrsvpedv
nucleocapsid
n
protein
monoclon
antibodi
antigapdh
monoclon
antibodi
proteintech
final
membran
incub
goatantimous
secondari
antibodi
boster
biolog
technolog
co
ltd
h
membran
visual
use
enhanc
chemiluminesc
system
amersham
imag
ge
healthcar
densitometri
analysi
level
nucleocapsid
protein
level
measur
imag
j
softwar
normal
gapdh
crystal
structur
prrsv
pdb
pedv
proteas
pdb
complex
structur
pedv
proteas
pdb
retriev
homolog
model
prrsv
pedv
compound
gener
use
autodock
softwar
root
mean
squar
deviat
rmsd
like
bind
pattern
analyz
use
pdbefold
http
pdbeorgfold
pymol
respect
amino
acid
sequenc
arteriviru
prrsv
eav
pedv
proteas
align
use
larkin
et
al
visual
espript
server
http
espriptibcpfr
robert
gouet
ic
cc
ec
determin
use
graphpad
prism
softwar
graphpad
softwar
san
diego
ca
experi
perform
triplic
valu
standard
deviat
sd
shown
signific
differ
determin
use
student
ttest
p
consid
signific
compar
control
group
p
consid
highli
signific
p
consid
extrem
signific
librari
lead
compound
screen
prrsv
use
fret
assay
preliminari
screen
done
prrsv
substrat
compound
five
compound
inhibit
proteas
activ
condit
select
ic
measur
fig
compound
design
compound
shown
fig
spec
id
number
respect
tabl
detail
inform
shown
tabl
evalu
inhibitori
effect
activ
ad
differ
concentr
compound
proteas
reaction
mixtur
percentag
inhibit
calcul
base
observ
fluoresc
compound
show
concentrationdepend
inhibit
inhibit
level
reach
high
fig
ic
valu
estim
nonlinear
regress
compound
compound
compound
compound
compound
meanwhil
effect
dmso
activ
also
determin
fig
interestingli
activ
exhibit
concentrationdepend
trend
along
increas
dmso
concentr
may
lead
high
ic
valu
evalu
suppress
prrsv
replic
compound
ad
compound
prrsvinfect
cell
rang
concentr
ec
valu
compound
estim
respect
fig
furthermor
three
compound
show
low
cytotox
cc
valu
compound
estim
fig
respect
wherea
cell
viabil
higher
presenc
compound
fig
although
signific
cytotox
observ
concentr
higher
compound
strongli
inhibit
prrsv
infect
fig
b
henc
result
show
compound
significantli
inhibit
prrsv
replic
noncytotox
concentr
si
valu
approxim
respect
tabl
interestingli
observ
ec
higher
ic
may
due
presenc
membran
barrier
high
proteas
concentr
use
fret
assay
previous
report
kumar
et
al
quantifi
inhibitori
effect
compound
detect
prrsv
nucleocapsid
n
protein
express
western
blot
fig
prrsv
n
protein
decreas
compound
dosedepend
manner
notabl
viral
n
protein
detect
presenc
compound
indic
compound
markedli
inhibit
prrsv
propag
cell
compound
substanti
suppress
prrsv
replic
fig
differ
molecular
structur
may
caus
weak
inhibitori
effect
prrsv
replic
prrsv
pedv
belong
order
nidoviral
possess
similar
genom
organ
strategi
nonstructur
structur
protein
express
ziebuhr
et
al
henc
evalu
inhibitori
effect
compound
pedv
proteas
activ
fret
assay
compound
show
concentrationdepend
inhibit
inhibit
level
reach
high
fig
ic
valu
compound
compound
estim
nonlinear
regress
meanwhil
abil
compound
block
pedv
replic
also
evalu
pedv
strain
sensit
compound
ec
valu
respect
fig
pedv
n
protein
decreas
compound
dosedepend
manner
fig
furthermor
cc
valu
measur
vero
cell
fig
si
valu
approxim
tabl
respect
addit
result
show
proteas
activ
eav
inhibit
compound
fig
therefor
compound
behav
potenti
broadspectrum
antivir
agent
complex
crystal
structur
proteincompound
use
guid
organ
synthesi
highaffin
protein
ligand
enzym
inhibitor
de
kloe
et
al
studi
soak
prrsv
pedv
proteas
crystal
variou
concentr
compound
unfortun
unabl
obtain
complex
structur
therefor
potenti
bind
site
analyz
detail
use
molecular
simul
dock
compound
prrsv
pedv
proteas
structur
fig
b
complex
model
initi
posit
base
xray
structur
streptomyc
griseu
proteinas
e
sgpe
pdb
code
pedv
nienab
et
al
ye
et
al
grid
map
grid
point
center
substrat
complex
structur
cover
bind
pocket
popul
size
mutat
rate
crossov
rate
set
paramet
simul
perform
use
million
energi
evalu
maximum
gener
simul
perform
time
yield
dock
conform
lowest
energi
conform
regard
bind
conform
ligand
protein
wei
et
al
complex
model
compound
interact
proteas
via
extens
hydrogen
bond
hydrophob
forc
fig
b
activ
site
prrsv
consist
addit
specif
pocket
conserv
artertivirus
prrsv
eav
compris
correspond
eav
fig
tian
et
al
inde
activ
site
specif
pocket
prrsv
interact
compound
via
hydrogen
bond
hydrophob
forc
fig
pedv
activ
site
compos
specif
pocket
consist
analog
extens
interact
among
compound
activ
site
specif
pocket
also
observ
fig
henc
compound
may
block
recognit
combin
proteas
substrat
therebi
inhibit
prrsv
pedv
replic
multiplesequ
align
indic
amino
acid
sequenc
ident
prrsv
pedv
approxim
fig
moreov
distinct
differ
structur
proteas
rsmd
interestingli
activ
site
prrsv
correspond
pedv
conserv
fig
meanwhil
two
site
contact
compound
via
hydrogen
bond
hydrophob
forc
fig
b
may
reason
compound
exhibit
broadspectrum
activ
prrsv
pedv
porcin
reproduct
respiratori
syndrom
viru
prrsv
porcin
epidem
diarrhea
viru
pedv
major
threat
worldwid
swine
industri
current
inactiv
live
attenu
viru
vaccin
use
intens
pig
farm
although
reduc
mortal
current
use
vaccin
control
prrsv
pedv
infect
spread
furthermor
commerci
drug
avail
prevent
infect
nidovirus
proteas
key
player
viral
replic
xue
et
al
henc
develop
antivir
drug
target
proteas
would
becom
import
strategi
prevent
prrsv
pedv
outbreak
experi
compound
screen
target
proteas
use
identifi
inhibitor
suppress
prrsv
pedv
replic
meanwhil
elucid
bind
mechan
compound
proteas
simul
like
bind
conform
use
autodock
softwar
shi
et
al
veterinari
microbiolog
proteas
specif
pocket
essenti
recognit
side
chain
substrat
residu
determin
enzym
prefer
tian
et
al
ye
et
al
henc
residu
specif
pocket
select
target
molecul
dock
total
bind
conform
ligand
protein
obtain
lowest
energi
conform
use
analysi
shown
fig
b
compound
illustr
stick
amino
acid
residu
contact
compound
shown
line
signific
differ
residu
specif
pocket
prrsv
pedv
compound
dock
proteas
differ
conform
interact
fig
b
besid
due
semiflex
dock
perform
bind
conform
compound
proteas
also
exist
subtl
differ
nonetheless
interact
highli
similar
fig
b
otherwis
previou
studi
shown
substratebind
site
activ
site
proteas
locat
domain
ii
structur
tian
et
al
ye
et
al
amino
acid
residu
correspond
proteas
play
vital
role
substrat
combin
catalysi
inde
dock
analysi
result
suggest
compound
bind
substrat
channel
domain
ii
form
strongli
hydrophob
interact
hydrogen
bond
fig
henc
compound
would
broad
competit
inhibitor
bind
substratebind
channel
proteas
replac
substrat
addit
result
show
compound
could
effect
inhibit
replic
prrsv
pedv
micromolar
rang
unfortun
ec
valu
high
select
index
si
valu
less
fig
tabl
lead
compound
compound
low
molecular
weight
da
tabl
thu
medicin
chemistri
optim
avail
increas
select
index
pharmacokinet
properti
dmpk
moreov
substratebind
channel
proteas
larg
caviti
supplementari
studi
may
need
accur
character
compoundbind
site
fig
effect
compound
activ
prrsv
fret
assay
enzymat
activ
measur
use
substrat
compound
variou
concentr
percentag
inhibit
rfu
experiment
group
min
rfu
control
group
min
ic
determin
use
graphpad
prism
softwar
bar
repres
sd
three
replic
shi
et
al
veterinari
microbiolog
design
optim
inhibitor
norwalk
viru
felin
coronaviru
transit
state
proteas
inhibitor
design
synthes
exhibit
notabl
inhibitori
effect
viral
replic
tiew
et
al
kim
et
al
therefor
transit
state
compound
optim
gener
hydrophob
interact
hydrogen
bond
side
chain
amino
acid
residu
need
anim
studi
also
conduct
develop
antivir
drug
prrsv
pedv
futur
final
result
emphas
feasibl
develop
antiprrsv
antipedv
inhibitor
new
class
broadspectrum
antivir
drug
treatment
exposur
viral
agent
emerg
highli
virul
prrsv
pedv
strain
widespread
preval
worldwid
serious
affect
constrain
develop
pig
farm
industri
studi
identifi
novel
antivir
inhibitor
target
prrsv
design
compound
two
compound
could
substanti
inhibit
prrsv
replic
moreov
compound
exhibit
broadspectrum
antivir
activ
target
pedv
proteas
inhibit
pedv
replic
result
help
guid
develop
new
broadspectrum
antivir
drug
prrsv
pedv
harvest
supernat
includ
prrsv
compound
use
tcid
assay
c
dosedepend
inhibit
prrsv
nucleocapsid
protein
product
compound
cell
treat
dmso
control
gapdh
load
intern
control
meanwhil
prrsv
n
protein
level
normal
gapdh
cc
ec
determin
use
graphpad
prism
softwar
bar
repres
sd
three
replic
p
consid
signific
compar
control
group
p
consid
highli
signific
p
consid
extrem
signific
shi
et
al
veterinari
microbiolog
fig
broadspectrum
inhibit
compound
pedv
effect
compound
proteas
activ
pedv
fret
assay
compound
variou
concentr
preincub
proteas
min
fluoresc
valu
measur
percentag
inhibit
calcul
fig
b
cell
viabil
analysi
compound
vero
cell
c
compound
inhibit
pedv
replic
vero
cell
tcid
assay
pedv
perform
fig
dosedepend
inhibit
pedv
nucleocapsid
protein
product
compound
vero
cell
treat
dmso
control
gapdh
load
intern
control
meanwhil
pedv
n
protein
level
normal
gapdh
ic
cc
ec
determin
use
graphpad
prism
softwar
bar
repres
sd
three
replic
p
consid
signific
compar
control
group
p
consid
highli
signific
p
consid
extrem
signific
shi
et
al
veterinari
microbiolog
